Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Business News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
Tags US Top News and Analysis Business News Europe News
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Breaking News: Earnings Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Health & Science Earnings Biotechnology
From CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
Tags Technology Dexcom Inc Abbott Laboratories
From CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
Tags Europe Markets Markets Alphabet Inc
From CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
Tags Alphabet Inc Markets Consumer prices
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Breaking News: Investing Health & Science Investment strategy
From CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
Tags Walmart Inc CVS Health Corp Sanofi SA
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Breaking News: Markets Obesity Exercise
From CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
Tags Breaking news Companies Health care industry
From CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Tickers BIRK EVS MSFT NVO
Tags Tempest Therapeutics Benzinga Tesla
From Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
Tags Investing Eli Lilly and Co Stock markets
From CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
Tags Markets Plug Power Inc Finance
From CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
Tags Timken Co Plug Power Inc Take/Two Interactive Software Inc
From CNBC.com News
LVMH shares fall to 2023 low as growth slows, pulling luxury sector down
Tags Novo Nordisk A/S LVMH Moet Hennessy Louis Vuitton SE Europe Markets
From CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Tickers CEO
Tags Mergers and acquisitions Retail industry Weight management
From CNBC.com News
Here are 20 stocks I'm watching Tuesday, including Lilly, AMD and Goldman Sachs
Tags Breaking News: Markets Qorvo Inc Skyworks Solutions Inc
From CNBC.com News
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb
Tags Investment strategy SoFi Technologies Inc Markets
From CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
Tags Business News Johnson & Johnson Pharmaceuticals
From CNBC.com News
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
Tags Kellogg Co Retail industry PepsiCo Inc/
From CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
Tags Health care industry Pfizer Inc Companies
From CNBC.com News
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
Tags Breaking news Companies Health care industry
From CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
Tags Weight management Companies Social issues
From CNBC.com News
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
Tags Companies Breaking news Lawsuits
From CNBC.com News
Here's why Jim Cramer likes J.M. Smucker's plan to buy the maker of Twinkies
Tags CNBC Investing Club Investment strategy Markets
From CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
Tags Business News Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
Tags Health & Science Eli Lilly and Co CNBC Global CFO Council
From CNBC.com News
Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia
Tags Eli Lilly and Co Science Health & Science
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.